Acesso livre
Acesso livre

Arquivos do dia: Outubro 14, 2021

[Preprint] Em estudo randomizado com 29.949 participantes, a vacina Novavax demonstrou alta eficácia geral (> 90%) na prevenção de Covid-19, e todos os casos moderados a graves ocorreram no grupo placebo.

14 Out, 2021 | 10:55h

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico – medRxiv

Comentário: Novel vaccine demonstrates high efficacy for prevention of COVID-19 – News Medical

Contéudos relacionados:

RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths.

Opinion | The mRNA vaccines are extraordinary, but Novavax is even better.

(Press release – not published yet) Novavax COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease.

RCT: Novavax vaccine is 49.4% effective against B.1.351 SARS-CoV-2 variant.

[Press release – not published yet] Novavax reports 96% efficacy against original strain of COVID-19, 86% efficacy against B.1.1.7 variant, and 55% efficacy against B1.351 variant

New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant

 

Comentário no Twitter

 


Revisão sistemática | Taxas de sequelas pós-agudas da infecção por SARS-CoV-2 no curto e no longo prazos.

14 Out, 2021 | 10:53h

Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review – JAMA Network Open

Comentários:

Most COVID-19 survivors have symptoms 6 months on, review finds – CIDRAP

Expert reaction to systematic review on rates of postacute sequelae of SARS-CoV-2 infection (PASC) – Science Media Centre

How many people get ‘long COVID’? More than half, researchers find – Penn State

Conteúdos relacionados:

WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).

Characterizing long COVID: a living systematic review.

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)

 

Comentário no Twitter

 


Como ser um bom comunicador científico.

14 Out, 2021 | 10:51h

How to be a good science communicator – Nature Medicine

 

Comentário no Twitter

 


Como o Covax falhou em sua promessa de vacinar o mundo – “Covax, descrito como ‘ingenuamente ambicioso’ por um especialista, contribuiu com apenas 5% de todas as vacinas administradas globalmente.”

14 Out, 2021 | 10:49h

How Covax failed on its promise to vaccinate the world – The Bureau of Investigative Journalism

Conteúdos relacionados:

Perspective | A beautiful idea: how COVAX has fallen short.

WHO Launches Strategy to Achieve Global Covid-19 Vaccination by mid-2022.

WHO special envoys: To beat Covid, there’s a simple lesson – no one’s safe until everyone’s safe.

Joint COVAX Statement on the Equal Recognition of Vaccines – COVAX urges all government authorities to recognize as fully vaccinated all people who have received COVID-19 vaccines that have been deemed safe and effective by WHO.

WHO COVAX Joint Statement: Call to action to equip COVAX to deliver 2 billion doses in 2021.

Covax: How will Covid vaccines be shared around the world?


Vídeo | Pílula da Merck contra a Covid transforma o tratamento. É assim que ela funciona.

14 Out, 2021 | 10:48h

Watch: Merck’s Covid pill could transform treatment. Here’s how it works – STAT

Conteúdos relacionados:

How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.


OMS fornece orientação direcionada para a falta de serviços de cuidados paliativos.

14 Out, 2021 | 10:47h

Comunicado de imprensa: WHO takes steps to address glaring shortage of quality palliative care services – World Health Organization

Ver Diretriz:

Assessing the development of palliative care worldwide: a set of actionable indicators – World Health Organization

Quality health services and palliative care: practical approaches and resources to support policy, strategy and practice – World Health Organization

 

Comentário no Twitter (fio – clique para saber mais)

 


Hemodiálise em casa: currículo principal 2021.

14 Out, 2021 | 10:44h

Home Hemodialysis: Core Curriculum 2021 – American Journal of Kidney Diseases

 

Comentário no Twitter

 


Diretrizes ASH 2021 para transplante de célula-tronco em pacientes com doença falciforme.

14 Out, 2021 | 10:43h

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation – Blood

Comunicado de imprensa: ASH Releases New Clinical Practice Guidelines on Stem Cell Transplantation in Sickle Cell Disease

Comentário: ASH Issues Guideline on the Use of HSCT for Sickle Cell Disease – HealthDay


Estudo randomizado | Ocitocina não melhora o funcionamento social em crianças com transtorno do espectro autista.

14 Out, 2021 | 10:42h

Comunicado de imprensa: Oxytocin does not improve social functioning in children with autism spectrum disorder, NIH-funded study suggests – National Institutes of Health

Estudo original: Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder – New England Journal of Medicine


M-A | Desfechos pós-troca de válvula aórtica transcateter em anatomia bicúspide vs. tricúspide – As taxas de sucesso dos dispositivos e de sobrevivência em 1 ano são similares, mas pacientes com válvulas bicúspides têm um risco mais alto para complicações periprocedimento.

14 Out, 2021 | 10:40h

Outcomes After Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Anatomy: A Systematic Review and Meta-Analysis – JACC: Cardiovascular Interventions


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.